For the Inventor, By the Inventor

Enter assignee name

Vincenza, Italy

Zambon Group

USPTO Granted Patents = 138

CIPO Patents = 3

EPO Patents = 1

Trademarks = 2

Forward Citations = 955

Loading Chart...

Loading Chart...

124 inventors (with patents filed for the assignee):

Francesco Santangelo (31 out of 44 patents)

Claudio Giordano (22 out of 59 patents)

Franco Pellacini (21 out of 31 patents)

4. Gabriele Pietro Norcini (20 out of 45 patents)

5. Mauro Napoletano (19 out of 30 patents)

6. Marco Villa (18 out of 35 patents)

7. Maurizio Paiocchi (14 out of 19 patents)

8. Daniele Bonadeo (13 out of 14 patents)

9. Cesare Casagrande (13 out of 36 patents)

10. Federico Stroppolo (13 out of 15 patents)

11. Gabriele Morazzoni (12 out of 14 patents)

12. Dario Chiarino (12 out of 33 patents)

13. Annibale Gazzaniga (12 out of 14 patents)

14. Stefania Montanari (10 out of 11 patents)

15. Angelo Carenzi (10 out of 24 patents)

138 patents: Sort by Forward Citations

1. 7704960 - Macrolide compounds endowed with antiinflammatory activity (2010-04-27),

2. 7507721 - Macrolides with antiinflammatory activity (2009-03-24),

3. 7488811 - Macrolide compounds endowed with antiinflammatory activity (2009-02-10),

4. 7265251 - Process for the preparation of nitroalkenes (2007-09-04),

5. 7199266 - Process for the preparation of gabapentin (2007-04-03),

6. 6894164 - Process for the preparation of (pyridinylidene)-phthalides (2005-05-17),

7. 6833389 - Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections (2004-12-21),

8. 6706882 - Process for the preparation of (pyridinylidene)-phthalides (2004-03-16),

9. 6627659 - Methods of decreasing the effects of oxidative stress using N-acetylcysteine (2003-09-30),

10. 6589993 - Treating vancomycin-intermediates and multiresistant staphylococci infection with thiamphenicol or a salt thereof (2003-07-08),

11. 6589951 - Phthalazine derivatives as phosphodiesterase 4 inhibitors (2003-07-08),

12. 6548480 - Phosphonic acid derivatives with metallopeptidase inhibitory activity (2003-04-15),

13. 6525055 - Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors (2003-02-25),

14. 6498160 - Phthalazine derivatives as phosphodiesterase 4 inhibitors (2002-12-24),

15. 6492360 - Phthalazine derivatives phosphodiesterase 4 inhibitors (2002-12-10),

Zambon Group S.p.A. is a global pharmaceutical company based in Italy. With a rich history spanning over a century, Zambon specializes in the development, manufacturing, and commercialization of innovative medical solutions in various therapeutic areas. Committed to improving the health and well-being of individuals worldwide, Zambon strives to enhance patient outcomes through scientific research, high-quality products, and sustainable business practices.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

138 Patents

#1 in Vincenza

#55 in Italy

#5,706 in the World

Vincenza, Italy

Zambon Group

Forward Citations = 955

124 inventors:

Francesco Santangelo (31 out of 44 patents)

Claudio Giordano (22 out of 59 patents)

Franco Pellacini (21 out of 31 patents)

4. Gabriele Pietro Norcini (20 out of 45 patents)

5. Mauro Napoletano (19 out of 30 patents)

Please report any incorrect information to support@idiyas.com

Loading…